secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spectral AI, Inc. (MDAI)
CIK:        0001833498
Form:       8-K
Filed at:   2026-08-12T20:03:02+00:00
Accession:  0001213900-26-088341
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spectral AI Q2 loss narrows to $4.2M; FDA-cleared DeepView targets first sales by year-end
--------------------------------------------------------------------------------

- Q2 2026 R&D revenue $3.5M vs $5.1M YoY; gross margin 31.6% vs 45.2% on BARDA cost-share.
- Net loss $4.2M ($0.13/share) vs $8.0M loss ($0.31) YoY; adjusted EBITDA loss $(3.5)M vs $(1.7)M.
- Cash $14.0M at June 30, 2026; drew $6.5M under Avenue Capital credit facility post-FDA clearance.
- FDA De Novo clearance for DeepView burn indication received May 2026; first U.S. commercial sales targeted by year-end 2026.
- March 2026 BARDA advanced funding of $31.7M; new CFO David McGuire and CCO Darcy Bajko appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026088341/0001213900-26-088341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026088341/ea0301807-8k_spectral.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-088341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer